instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: "Ohio Sen. Rob Portman has been busy in Washington touting the Comprehensive Addiction Recovery Act in response to a shocking number of heroin overdoses in Ohio. The bill just passed in the Senate, 94-1. (Nebraska Sen. Ben Sasse was the sole ""nay,"" saying he believes that fighting addiction is a local issue.) Ohio ranks high on the list of states reeling from the national epidemic. In Montgomery County, which encompasses Dayton, Ohio, heroin-related deaths increased 225 percent between 2011 and 2015. Back in the 1970s, the heroin on U.S. streets was the ""black tar"" variety, and much of it came from southeast Asia. In 2010, 80 percent of the heroin in the world came from poppy fields in Afghanistan, according to the Office of National Drug Control Policy. So when Portman said that most of the heroin in America comes from Mexico's border, we were skeptical. Portman, it turns out, has done his homework. The Drug Enforcement Administration's National Drug Threat Assessment of 2015 says that Mexico is the primary supplier of heroin to the United States. ""Southeast Asia was once the dominant supplier of heroin in the United States, but Southeast Asian heroin is now rarely detected in U.S. markets,"" the report state. ""Mexico and, to a lesser extent, Colombia dominate the U.S. heroin market, because of their proximity, established transportation and distribution infrastructure, and ability to satisfy U.S. heroin demand."" The report also says that Mexican ""transnational criminal organizations,"" (the DEA's term for drug-dealing gangs) ""pose the greatest criminal drug threat to the United States; no other group is currently positioned to challenge them."" The National Drug Threat report notes that Colombian gangs were traditionally the suppliers of wholesale cocaine and heroin to Mexican and Dominican groups. But cartels in Mexico are ramping up their roles on the supply side -- opium production in Mexico increased by 50 percent in 2014. Mexican labs also produce fentanyl, a synthetic painkiller that is 80 to 100 times stronger than morphine. Fentanyl is sometimes mixed with heroin or substituted for heroin, and the DEA reports more than 700 overdoses attributed to fentanyl between late 2013 and early 2015. Drugs get past the U.S. borders mostly ""by land, not by sea,"" said Homeland Security Secretary Jeh Johnson, in the same March 8 hearing with Portman. And a 2015 Washington Post series on the surge of heroin puts the border detection rate at a scant 1.5 percent. Smugglers' creativity defies gravity: One successful bust came when agents caught two men flying a drone carrying 28 pounds of heroin from Mexico to California. Our ruling Portman said that heroin is coming to the United States primarily from Mexico. He hasn't been studying drug facts for nothing." Claim: We understand that this heroin is primarily coming from Mexico, over the border.
answer:
Portman said that heroin is coming to the United States primarily from Mexico. He hasn't been studying drug facts for nothing.

question:
Paragraph: After complaints about taste and costs, the Trump administration rolled back a rule that required foods like pasta and bread be made with whole grains. The cafeteria directors who lobbied for the change say they just want greater flexibility to serve foods like white bread which are more processed and have less fiber when whole grains don't work. In Vermont, the relaxed rule means white rice will be served with beans again. In Oregon, macaroni and cheese may return. And in South Dakota, students may notice a change with their soup. "The staff asked right away, 'Oh my God, can we go back to the other saltines?'" said Gay Anderson, a school lunch director and president of the School Nutrition Association, which represents cafeteria operators and suppliers like Domino's and Kellogg. The rollback addresses rules on grains, milk and salt championed by former first lady Michelle Obama. Since 2014, schools had been required to serve only whole grain versions of food as part of the national school lunch program, a critical source of free and reduced-price meals for millions of children. The idea is that whole grains would be more nourishing and help cultivate healthy habits amid alarming obesity rates . The Center for Science in the Public Interest, which is among the parties suing over the rollback, notes the standards were based on the government's own dietary guidelines and that most schools were successfully meeting them. But cafeteria operators said costs were higher, cooking was more difficult and students were throwing away more food. The School Nutrition Association said it's more important that children who rely on the lunches eat something, and that the rule ignored cultural preferences, such as for flour tortillas in the Southwest or for white rice among Asian students. To ease the transition to whole grains, the U.S. Department of Agriculture let schools apply for temporary waivers to serve select dishes that didn't meet the whole-grain rule. For the last school year, it said about 20 percent of districts asked permission to serve refined grains that are enriched to add back some nutrients. Among the frequently waived foods were pasta , pizza , tortillas and biscuits , which one Georgia lunch official joked affects the "tests scores of rednecks ," according to records obtained by The Associated Press from state agencies. Other waived foods included beignets, cinnamon rolls, corn dogs, sugar cookies and Pop Tarts. One district requested a waiver for croissants because it said students don't like the whole-grain version. "Plus they are 20 cents more per serving," the district said. Then in December, Agriculture Secretary Sonny Perdue said the USDA was going back to the old standard: At least half of grain foods must be rich in whole grains. The agency said that does away with the red tape of making schools get waivers, and gives schools more flexibility to offer wholesome meals that also reduce food waste. Whitney Ellersick, a school lunch director in Portland, Oregon, said the change means her district will no longer need a waiver for its lasagna. But she was surprised by the extent of the rollback. "I was a little shocked to see it go to 50 percent," Ellersick said. The Center for Science in the Public Interest said the USDA's rollback may be halting progress made by schools, which could be tempted to bring back more refined grains that cost less or are easier to make. Already, the group notes the USDA defines "whole grain rich" as being half whole grain, meaning there's built-in wiggle room to make bread and pasta students won't mind. Bettina Elias Siegel of The Lunch Tray website also noted a recent USDA report that found that "plate waste" was comparable before and after the rules were implemented in 2014, undermining arguments they were prompting students to throw away more food. The report also found that students took advantage of lunches more often in schools with healthier lunches. The American Heart Association likewise criticized the decision to relax the rules and called on school districts to stick to the previous standards, which also included stricter rules on salt and milk. Among the districts that plan to do so is Boston, where fifth grader Trinity Wilson likes the brown rice. She said it's is healthier than white rice. "I know that because my mom told me," Wilson said. But some school lunch officials say the rollback could help smaller districts that don't have access to as many products. In Arkansas, students in the Magnet Cove district accepted whole-grain Pop Tarts and other changes, officials say, but still prefer the old noodles, biscuits and rolls. "They're tastier, softer and fluffier," said Danny Thomas, the district's superintendent. In Burlington, Vermont, white rice and beans can return to menus. Doug Davis, the district's food director and incoming president of the School Nutrition Association, said it's a healthy dish that students will actually eat. To avoid buying two types of rice, Davis said white rice will likely also be used in stir fries and soups. He plans to stick mostly to whole grains, but he appreciates not having to. Whole-grain pasta isn't ideal for mac and cheese, Davis noted. "Would we make a change on that? I don't know," he said. ____ Follow Candice Choi at www.twitter.com/candicechoi ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content. Claim: With Trump rollback, school lunch could get more white bread.
answer:
Is white bread about to make a comeback on school lunch menus?

question:
Paragraph: As the drug is still under development, there was no discussion of costs. This is a humanized monoclonal antibody and the story might have mentioned some of the drugs currently on the market to treat other disorders such as bevacizumab (Avastin) or adalimub (Humira). This could have led to some discussion about costs because these are not inexpensive medications. The story merely mentions that this drug had 'shown promise' and that the studies reported are 'encouraging' because they indicate that people can tolerate the drug for 2- 4 years without safety concerns. Promise of what? What does the drug do? Although the story mentions amyloid accumulation, it failed to explain that though amyloid accumulation is seen in Alzheimer's disease, it isn't clear whether it causes symptoms or is secondary to the disease process. The story would have added valuable context by at least mentioning the results of the placebo-controlled study from which the patients in this extension study were drawn. http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-newsArticle&ID=1166655 That study found that the drug had no effect on symptoms in the study group overall, although specific subgroups seemed to benefit in an after-the-fact analysis that was not part of the original study design. The story indicated that some patients taking the higher does of the drug experiencedheadache, memory loss, hallucinations, reduced coordination or other symptoms. From the information in the story, it appeared that 8% (21/262) of patients participating in a second study using the lower dose of the medication had some anomalies on MRI scan but no reported symptoms. At the end of this story, it was reported that the results had only been presented at a meeting and therefore considered only as preliminary until they were reviewed. In addition, the story indicated that the study reported on was an open-label trial. But it doesn't explain what open-label means hardly a consumer-friendly term. Wanna do a poll on how many readers know what it means? (In an open-label trial, both the clinician and patient know what it is that they are taking; the potential impact of that on results should be obvious.) Nonethless, we'll give the story the benefit of the doubt, largely on the back of one of the expert sources being quoted: "it is too early to tell from the data from this small Phase 2 safety trial." (Although, again, do we expect that most readers know what a Phase 2 trial really means?). The story did not engage in overt disease-mongering. The story included a quote from Dr. Ian Murray who did not appear to have a role in the studies reported on as well as comments from Dr. Salloway, lead author of the study. But we're going to rule it unsatisfactory because the story should have noted that Dr. Salloway, according to previous disclosures available online, has received research funding and has consulting relationships with numerous drug companies, including Pfizer, which makes bapineuzumab. The story failed to explain how patients takingbapineuzumab compared with those who did not take the drug. Without this information, it is impossible to evaluate the value this medication may have to patients. The story also should have put the findings seen with bapineuzumab in context with those of the other approved drugs (Aricept, etc) that have limited efficacy or perhaps mentioned the other drugs that are in testing. The subject of the story is the drug bapineuzumab, which was reported as not yet available to consumers. It would have been useful to include a link to Clinicaltrials.gov so that readers who might be interested could learn about the other trials being conducted. http://clinicaltrials.gov/ct2/results?term=Bapineuzumab This story did not overstate the novelty of the drug reported on. But the story also could have mentioned that there are several similar drugs undergoing preliminary testing. This story did not rely solely on a news release. Claim: Experimental Drug Might Help Fight Alzheimer's After All
answer:
This story reports on a drug in development for people with Alzheimer's disease. While providing a lot of detailed information about the molecule under study and how the drug is better tolerated at lower doses, this story failed to provide any insight as to the benefit one might hope to obtain from taking this medication. Indicating that the drug might show promise gets the readers hopes up without any framework for what it is they might expect. The graying of the population means that the concern about Alzheimer's disease looms large for the elderly, people who care for elders, and those paying the bills.